Mimedx Group Inc’s filing revealed that its Officer Hulse William Frank IV acquired Company’s shares for reported $0.65 million on Mar 10 ’25. In the deal valued at $7.94 per share,81,446 shares were bought.
Then, Maersk-Moller Kimberly sold 2,111 shares, generating $17,743 in total proceeds. Upon selling the shares at $8.40, the Chief Commercial Officer now owns 265,271 shares.
Before that, Whitlow Ricci S sold 61,420 shares. Mimedx Group Inc shares valued at $508,558 were divested by the Chief Operating Officer at a price of $8.28 per share. As a result of the transaction, Whitlow Ricci S now holds 403,019 shares, worth roughly $3.27 million.
Cantor Fitzgerald initiated its Mimedx Group Inc [MDXG] rating to an Overweight in a research note published on July 02, 2024; the price target was $11. A number of analysts have revised their coverage, including Lake Street’s analysts, who began to cover the stock in early March with a ‘”a Buy”‘ rating. Craig Hallum began covering MDXG with “Buy” recommendation on October 27, 2023. Mizuho started covering the stock on October 13, 2022. It rated MDXG as “a Buy”.
Price Performance Review of MDXG
On Tuesday, Mimedx Group Inc [NASDAQ:MDXG] saw its stock jump 4.24% to $8.12. Over the last five days, the stock has gained 0.25%. Mimedx Group Inc shares have fallen nearly -15.59% since the year began. Nevertheless, the stocks have fallen -0.37% over the past one year. While a 52-week high of $10.14 was reached on 01/02/25, a 52-week low of $5.47 was recorded on 02/27/25. SMA at 50 days reached $8.58, while 200 days put it at $7.49.
Levels Of Support And Resistance For MDXG Stock
The 24-hour chart illustrates a support level at 7.83, which if violated will result in even more drops to 7.54. On the upside, there is a resistance level at 8.30. A further resistance level may holdings at 8.48. The Relative Strength Index (RSI) on the 14-day chart is 46.78, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.11, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 31.34%. Stochastics %K at 50.90% indicates the stock is a holding.
The most recent change occurred on July 26, 2021 when Northland Capital began covering the stock and recommended ‘”an Outperform”‘ rating along with a $23 price target.
